Race and prostate cancer: What do we know?

Prostate Journal

Volumn 2, Issue 1, 2000, Pages 33-41

  Dale Young, C ^a   Roach III, Mack ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SURVIVAL; HUMAN; MALE; NEGRO; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RACE DIFFERENCE;

EID: 0033973074     PISSN: 10955100     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1411.2000.15003.x     Document Type: Article

References (43)

1. Silverberg E. (1980) Cancer statistics. Cancer Statistics 30: 23.
2. Walker AR, Walker BF, Segal I. (1993) Cancer patterns in three African populations compared with the United States black population. Eur. J. Cancer Prev. 2: 313-320.
3. Dale W, Vijayayakumar S, Lawlor EF, et al. (1996) Prostate cancer, race, and socioeconomic status: Inadequate adjustment for social factors in assessing racial differences. Prostate 29: 271-281.
4. Godley PA, Campbell MK, Miller C, et al. (1996) Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United Stated males with and without prostatic carcinoma. Cancer Epidemiol. Biomarkers Prev. 5: 115-119.
5. Demark-Wahnefried W, Strigo T, Catoe K, et al. (1995) Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 46: 346-351.
6. Hiatt RA, Armstrong MA, Klatsky AL, et al. (1994) Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 5: 66-72.
7. Carter BS, Bova GS, Beaty TH, et al. (1993) Hereditary prostate cancer: Epidemiological and clinical features. J. Urol. 1: 797-802.
8. Wu AH, Whittemore AS, Kolonel LN, et al. (1995) Serum androgens and sex hormonebinding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol. Biomarkers Prev. 4: 735-741.
9. Roach M. (1998) Is race an independent prognostic factor for survival from prostate cancer? J. Natl. Med. Assoc. 90: S713-S719.
10. Crawford ED, Blumenstein B A, Goodman PJ, et al. (1990) Leuprolide with and without Flutamide in advanced prostate cancer. Cancer 66: 1039-1044.
11. Kennealey GT, Vogelzang NJ, Soloway MS, et al. (1996) Analysis of time to treatment failure by extent of disease and race in a randomized, multicenter trial comparing Casodex (biclutamide) (C) with Eulexin (flutamide) (E), each combined with Luteinizing Hormone Releasing Hormone. Proc. Am. Soc. Clin. Oncol. Annu. Meet. 15: 251.
12. Vogelzang NJ, Chodak GW, Soloway MS, et al. (1995) Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial: Zolodex Prostate Study Group. Urology 46: 220-226.
13. Roach M, Krall J, Perez CA, et al. (1992) The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int. J. Radiat. Oncol. Biol. Phys. 24: 441-449.
14. Roach M, Lu JD, Pilepich MV, et al. (1998) Long term survival in 1500 men treated for prostate cancer with radiotherapy alone: Radiation Therapy Oncology Group Protocols 7706, 7506, 8531 and 8610. J. Urol. 159(Suppl):219. Abstract.
15. Smith DC, Trump DL, Vogelzang NJ, et al. (1996) The effect of African American race on response and survival in phase II trials of patients with hormone-refractory prostate cancer. Proc. Am. Soc. Clin. Oncol. Annn. Meet. 15(Suppl): 242.
16. Moul JW, Douglas TH, McCarthy WF, et al. (1996) Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J. Urol. 155: 1667-1673.
17. Perez CA, Garcia D, Simpson JR, et al. (1989) Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother. Oncol. 16: 1-21.
18. Powell IJ, Schwartz K, Hussain M. (1995) Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology 46: 825-830.
19. Kim JA, Kuban DA, El-Mahdi EM, et al. (1995) Carcinoma of the prostate: Race as a prognostic indicator in definitive radiation therapy. Radiology 194: 545-549.
20. Austin J-P, Aziz H, Potters L, et al. (1990) Diminished survival of young blacks with adenocarcinoma of the prostate. Am. J. Clin. Oncol. 13: 465-469.
21. Aziz H, Rotman M, Thelmo W, et al. (1988) Radiation-treated carcinoma of the prostate. Am. J. Clin. Oncol. 11: 166-171.
22. Dayal HH, Chiu C. (1982) Factors associated with racial differences in survival for prostatic carcinoma. J. Chronic Dis. 35: 553-560.
23. Epstein JI, Paull G, Eggleston JC, et al. (1986) Prognosis of untreated stage Al prostatic carcinoma: A study of 94 cases with extended followup. J. Urol. 136: 837-839.
24. Fowler JE Jr, Terrell F. (1996) Survival in blacks and whites after treatment for localized prostate cancer. J. Urol. 156: 133-136.
25. Hussain F, Aziz H, Macchia R, et al. (1992) High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean island immigrants. Int. J. Radiat. Oncol. Biol. Phys. 24: 451-461.
26. Lawton CA, Cantrell JE, Derus SW, et al. (1994) Prostate cancer: Are racial differences in clinical stage and survival explained by differences in symptoms? Radiology 192: 37-40.
27. Levine RL, Wilchinsky M. (1979) Adenocarcinoma of the prostate: A comparison of the disease in blacks versus whites. J. Urol. 121: 761-762.
28. Weinberger M, Williams B, Davis T, et al. (1996) Low literacy scores predict advanced stage prostate cancer presentation in African-American men. Am. Urol, Assoc. 155: 606A.
29. Nautiyal J, Vaida F, Awan A, et al. (1996) The impact of race on biochemical outcome in patients receiving irradiation for prostate cancer. Int. J. Radial Oncol Biol. Phys. 36:305.
30. Hart KB, Porter AT, Reddy S, et al. (1996) The relationship of race to the presentation and natural history of prostate cancer. Proc. Am. Soc. Clin. Oncol. Annu. Meet. 15: 247.
31. Austin J-P, Convery K. (1993) Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am. J. Clin. Oncol. 16: 140-145.
32. Mettlin C, Murphy GP, Menck H. (1994) Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990. Urology 43: 488-492.
33. Murphy GP. (1981) Prostate cancer today. Urology 17: 1-3.
34. Natarajan N, Murphy GP, Mettlin C. (1989) Prostate cancer in blacks: An update from the American College of Surgeons' patterns of care studies. J. Surg. Oncol. 40: 232-236.
35. Optenberg SA, Thompson IM, Friedrichs P, et al. (1995) Race, treatment, and long-term survival from prostate cancer in an equalaccess medical care delivery system. JAMA. 274:1599-1605.
36. Page WF, Kuntz AJ. (1980) Racial and socioeconomic factors in cancer survival. Cancer 45:1029-1040.
37. Pienta KJ, Demers R, Hoff M, et al. (1995) Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology 45: 93-102.
38. Robbins AS, Whittemore AS, Van Den Eeden SK. (1998) Race, prostate cancer survival, and membership in a large health maintenance organization. J. Natl. Cancer Inst. 90: 986-990.
39. Coleman CW, Lewis PP, Kroll SM, et al. (1997) An analysis of pretreatment characteristics and the risk of PSA failure by race and ethnicity in prostate cancer patients treated with definitive radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 39(Suppl): 2107. Abstract.
40. Hart KB, Wood DP, Tekyi-Mensah S, et al. (1998) The impact of race on biochemical disease-free survival in early stage prostate cancer patients treated with surgery or radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 42(Suppl): 2153. Abstract.
41. Zagars GK, Pollack A, Pettaway CA. (1998) Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablation. Int. J. Radiat. Oncol. Biol. Phys. 42: 517-523.
42. Altsman K, Kupelian PA, Sohayda G, et al. (1998) Race is not an independent factor affecting outcome after radical prostatectomy or definitive radiotherapy for localized adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 42(suppl): 2152. Abstract.
43. Powell IJ, Banerjee M, Sakr W, et al. (1999) Should African American men be tested for prostate cancer at an earlier age than Caucasian men? Cancer 85: 472-477.